Airsculpt Technologies Inc (AIRS)
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at Airsculpt Technologies Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Appears in These Scanners
This stock currently matches 5 of our scanner strategies — each hit links to the scanner.
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. View all scanners
Trading Day
Key levels of the most recently completed trading day — not a live quote.
52-Week Range
Current price 4.90 $ — 33% of the range above the low.
Lowest and highest closing price over the last 52 weeks. The marker shows where the current price sits within that range: close to the high speaks for strength, close to the low for weakness.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 08/04/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
AAQS
1/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 24.3%
- Exp. sales growth 3Y > 5% 1.7%
- EBIT growth 10Y > 5% –
- Exp. EBIT growth 3Y > 5% 1.7%
- Net debt < 4x EBIT –
- EBIT positive, 10Y straight 4
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% –
- ROCE > 15% -3.0%
- Expected return > 10% 1.9%
View all AAQS quality stocks · Read the methodology at AlleAktien
Source: fundamental data
AI Rating
–Not yet rated — we only show a category once an SEC-backed file with at least two cited passages is available. How the Rating Is Built
Growth Score
3 of 10 Weak growthTen checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years -3.5% failed
- More than 10% revenue growth is expected for the coming year 2.5% failed
- Share count grows by less than 3% a year 2.8% passed
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -15.4% failed
- Gross margin at 40% or higher and without meaningful erosion 59.4% failed
- Goodwill from acquisitions does not grow faster than revenue 43.6% failed
- Net debt below twice EBITDA 61.5 x EBITDA failed
- Operating cash flow covers the profits of the last three years 63 m passed
- Return on capital at 15% or higher, or up versus two years ago -3.0% failed
- Insiders hold at least 10% or are net buyers 43.1% passed
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Highlighted are things our editorial team noticed: green = stands out as strong, red = deserves a closer look. No single metric is a verdict on its own — always read it in context.
Analysts & Price Target
The price target sits 27.6% above the current price.
- Consensus
- Hold
- Analyst Ratings
- 4
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -0.02 | -0.02 – -0.02 | 153 | 66.7% | 1 |
| 12/31/2027 | 0.01 | 0.01 – 0.01 | 157 | 150.0% | 1 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Next Reporting Date
- Expected Earnings per Share
- 0.02 $
Expected date of the next quarterly or annual figures. Dates do shift occasionally — only the invitation issued by the company is binding.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
Quarterly Figures
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | -0.07 | – | 39 | -17.70 | -12.80 | 3 | -1 |
| 2025: Q1 | -0.04 | -147.20 | 39 | -17.30 | -7.20 | 1 | -1 |
| 2025: Q2 | -0.01 | – | 44 | -13.70 | -1.30 | 5 | 5 |
| 2025: Q3 | -0.13 | – | 35 | -17.80 | -27.20 | 0 | 0 |
| 2025: Q4 | 0.02 | – | 33 | -14.60 | 3.80 | -3 | -3 |
| 2026: Q1 | -0.03 | – | 39 | 0.00 | -6.10 | 5 | 5 |
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Annual Figures
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2019 | 41 | 1 | -2 | -0.04 | 5 | 120 | 172 |
| 2020 | 63 | 10 | 8 | 0.14 | 14 | 124 | 180 |
| 2021 | 133 | 16 | 11 | 0.19 | 27 | 84 | 201 |
| 2022 | 169 | -5 | -15 | -0.26 | 24 | 71 | 201 |
| 2023 | 196 | 9 | -4 | -0.08 | 24 | 84 | 204 |
| 2024 | 180 | -2 | -8 | -0.14 | 11 | 79 | 210 |
| 2025 | 152 | -5 | -12 | -0.19 | 3 | 88 | 187 |
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
About the Company
AirSculpt Technologies, Inc. fungiert zusammen mit seinen Tochtergesellschaften als Holdinggesellschaft für EBS Intermediate Parent LLC, die Body-Contouring-Verfahren in den USA und Kanada anbietet.
| Employees | 330 |
|---|---|
| Headquarters | Miami Beach, FL |
| Address | 1111 Lincoln Road, 33139 Miami Beach, United States |
| Phone | 786 709 9690 |
| Website | airsculpt.com |
| IPO Date | 29. Oct 2021 |
| ISIN | US0094961002 |
Management
| Name | Title | Birth Year |
|---|---|---|
| Yogesh Jashnani | CEO & Director | 1982 |
| Michael J. Arthur | Chief Financial Officer | 1988 |
| Brent R. Wadman J.D. | General Counsel | 1972 |
| Stephanie Evans Greene | Chief Marketing Officer | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 17. Apr 2026 | Jorey Chernett | Major Shareholder | Buy | 40,000 | 2.54 | 101,600 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
View all insider transactions →Chart
Interactive price chart (TradingView).
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.